[Diagnosis and treatment of paroxysmal nocturnal hemoglobinuria].
Kanakura
Yuzuru
Y
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D017326:Clinical Trials, Phase III as Topic; D055808:Drug Discovery; D006457:Hemoglobinuria, Paroxysmal / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics; D009154:Mutation; D011788:Quality of Life; D012015:Reference Standards
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D008565:Membrane Proteins; C080086:phosphatidylinositol glycan-class A protein; C481642:eculizumab